- $1.78bn
- $1.69bn
- $1.18bn
Brief: Omnicell Inc - On February 28, 2023, Company Committed To Further Reduce Its Headcount, As Part Of Plan
Brief: Omnicell Announces Fiscal Year And Fourth Quarter 2022 Results
Omnicell Inc reports results for the quarter ended in December - Earnings Summary
Omnicell Inc expected to post earnings of 9 cents a share - Earnings Preview
Omnicell Inc expected to post earnings of 10cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Autoliv, First Hawaiian, CN Energy Group
U.S. STOCKS ON THE MOVE-Senti Biosciences, Autoliv, Nexstar Media
Piper Sandler raises Omnicell PT; confident on product cycle
U.S. STOCKS ON THE MOVE-UniQure, Select Energy Services, Service Corporation International
U.S. STOCKS ON THE MOVE-Chegg, Yum Brands, Humana
Omnicell hits over 4-year low after lowering FY forecast
Brief: Omnicell Inc Reports Q3 GAAP Earnings Per Share Of $0.37
Omnicell Inc reports results for the quarter ended in September - Earnings Summary
Omnicell plunges after lowering FY forecast
Omnicell Inc expected to post earnings of 95cents a share - Earnings Preview
Brief: Omnicell Launches Specialty Pharmacy Services To Support Optimized Outpatient Medication Management And Drive Clinical And Business Outcomes For Health Systems
U.S. RESEARCH ROUNDUP-First Advantage, Renovacor, Sotera Health
U.S. RESEARCH ROUNDUP-Adobe, Benefitfocus, Fedex
U.S. RESEARCH ROUNDUP- Carvana, McKesson, Nektar Therapeutics